Gemmer Asset Management LLC Regenxbio Inc. Transaction History

Gemmer Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$27.01 - $40.26 $2,701 - $4,026	-100 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$27.75 - $43.44 $2,775 - $4,344	100 New	100 $4,000
Q1 2020 May 01, 2020	SELL	$21.5 - $54.2 $1,354 - $3,414	-63 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$34.54 - $44.87 $2,176 - $2,826	63 New	63 $3,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.